CCM

Catalio Capital Management Portfolio holdings

AUM $566M
1-Year Est. Return 106.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+106.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$541M
AUM Growth
+$64M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$31.5M
2
+$20M
3
+$12.4M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$11.6M
5
IRON icon
Disc Medicine
IRON
+$11.1M

Top Sells

1
+$30.6M
2
+$25.2M
3
+$19.6M
4
CORT icon
Corcept Therapeutics
CORT
+$17.6M
5
BBIO icon
BridgeBio Pharma
BBIO
+$14.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARA icon
26
Protara Therapeutics
TARA
$316M
$6.53M 1.21%
1,500,793
-125,577
SEPN
27
Septerna Inc
SEPN
$1.29B
$5.54M 1.02%
294,360
CDTX
28
DELISTED
Cidara Therapeutics
CDTX
$5.11M 0.94%
+53,333
KYTX icon
29
Kyverna Therapeutics
KYTX
$483M
$3.52M 0.65%
586,909
ELDN icon
30
Eledon Pharmaceuticals
ELDN
$221M
$2.75M 0.51%
+1,061,132
OM icon
31
Outset Medical
OM
$58.2M
$1.67M 0.31%
118,279
-48,387
MGX icon
32
Metagenomi Therapeutics
MGX
$55.6M
$1.25M 0.23%
528,993
ATAI icon
33
AtaiBeckley Inc
ATAI
$1.23B
$1.04M 0.19%
196,858
HYPR icon
34
Hyperfine
HYPR
$104M
$993K 0.18%
684,541
-75,494
MLTX icon
35
MoonLake Immunotherapeutics
MLTX
$1.3B
$955K 0.18%
133,131
-29,465
KPTI icon
36
Karyopharm Therapeutics
KPTI
$161M
$935K 0.17%
142,984
-3,029
PVLA
37
Palvella Therapeutics
PVLA
$1.59B
$753K 0.14%
+12,010
SNSE icon
38
Sensei Biotherapeutics
SNSE
$37.9M
$139K 0.03%
14,718
GILD icon
39
Gilead Sciences
GILD
$179B
– –
-226,875
HALO icon
40
Halozyme
HALO
$7.95B
– –
-191,529
MRSN
41
DELISTED
Mersana Therapeutics
MRSN
– –
-62,697
REPL icon
42
Replimune Group
REPL
$666M
– –
-330,337
TEVA icon
43
Teva Pharmaceuticals
TEVA
$36.2B
– –
-1,170,372
VIR icon
44
Vir Biotechnology
VIR
$1.5B
– –
-388,303
WGS icon
45
GeneDx Holdings
WGS
$2.58B
– –
-61,507
BCAX
46
Bicara Therapeutics
BCAX
$1.01B
– –
-97,800
ZBIO
47
Zenas BioPharma
ZBIO
$1.36B
– –
-215,314
CORT icon
48
Corcept Therapeutics
CORT
$3.6B
– –
-239,125
EW icon
49
Edwards Lifesciences
EW
$47.4B
– –
-390,932
FULC icon
50
Fulcrum Therapeutics
FULC
$544M
– –
-188,304
1
2